Treatments for COVID-19 Commissioner: Health Canada Funder: Canadian Institutes of Health Research (CIHR) through the Drug Safety and Effectiveness Network (DSEN) Share Buttons [ssba-buttons] Impact for Knowledge UsersProtocol The results of this rapid review will be shared with Health Canada to address their query on the effectiveness and safety of treatments for Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and (COVID-19) Open Science Framework registration Protocol brief Related Projects: Coronavirus: Safety of Antiviral or Antibody Treatments Category : KS Projects Date : 07 May 2020 Coronavirus: Safety of Antiviral or Antibody Treatments (Prev Entry) (Next Entry) Barriers and Facilitators to Uptake of Systematic Reviews